$2.34T
Total marketcap
$90.96B
Total volume
BTC 49.95%     ETH 15.43%
Dominance

Bio Vitos Pharma AB (publ) HEMC.ST Stock

0.23 SEK {{ price }} 0.000000% {{change_pct}}%
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
8.63M SEK
LOW - HIGH [24H]
0.0000 - 0.0000 SEK
VOLUME [24H]
0 SEK
{{ volume }}
P/E Ratio
0
Earnings per share
0 SEK

Bio Vitos Pharma AB (publ) Price Chart

Bio Vitos Pharma AB (publ) HEMC.ST Financial and Trading Overview

Bio Vitos Pharma AB (publ) stock price 0.23 SEK
Previous Close 0.31 SEK
Open 0.29 SEK
Bid 0.31 SEK x 0
Ask 0.33 SEK x 0
Day's Range 0.29 - 0.31 SEK
52 Week Range 0.16 - 1.25 SEK
Volume 5.12K SEK
Avg. Volume 192.93K SEK
Market Cap 10.69M SEK
Beta (5Y Monthly) 1.067432
PE Ratio (TTM) N/A
EPS (TTM) 0 SEK
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

HEMC.ST Valuation Measures

Enterprise Value 8.38M SEK
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.5760965
Price/Book (mrq) 0.49053627
Enterprise Value/Revenue 2.021
Enterprise Value/EBITDA -0.627

Trading Information

Bio Vitos Pharma AB (publ) Stock Price History

Beta (5Y Monthly) 1.067432
52-Week Change -37.67%
S&P500 52-Week Change 20.43%
52 Week High 1.25 SEK
52 Week Low 0.16 SEK
50-Day Moving Average 0.34 SEK
200-Day Moving Average 0.36 SEK

HEMC.ST Share Statistics

Avg. Volume (3 month) 192.93K SEK
Avg. Daily Volume (10-Days) 13.84K SEK
Shares Outstanding 34.37M
Float 23.62M
Short Ratio N/A
% Held by Insiders 37.77%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -341.66%
Gross Margin 78.72%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -32.20%
Return on Equity (ttm) -55.015%

Income Statement

Revenue (ttm) 4.15M SEK
Revenue Per Share (ttm) 0.14 SEK
Quarterly Revenue Growth (yoy) -53.00000000000000000000000000000000%
Gross Profit (ttm) 3.64M SEK
EBITDA -13367615 SEK
Net Income Avi to Common (ttm) -14139877 SEK
Diluted EPS (ttm) -0.31
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 2.03M SEK
Total Cash Per Share (mrq) 0.06 SEK
Total Debt (mrq) 0 SEK
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 2.82
Book Value Per Share (mrq) 0.634

Cash Flow Statement

Operating Cash Flow (ttm) -7075909 SEK
Levered Free Cash Flow (ttm) -4690900 SEK

Profile of Bio Vitos Pharma AB (publ)

Country Sweden
State N/A
City Solna
Address Nanna Svartz väg 4
ZIP 171 65
Phone 46 7 61 08 81 91
Website https://www.hemcheck.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 3

Hemcheck Sweden AB (publ) operates as a medical technology company in Sweden and internationally. The company develops and commercializes Helge, which detects hemolysis in vacuum tubes and blood gas samples. It serves emergency departments in the European Union and the United States. The company was incorporated in 2010 and is based in Solna, Sweden.

Q&A For Bio Vitos Pharma AB (publ) Stock

What is a current HEMC.ST stock price?

Bio Vitos Pharma AB (publ) HEMC.ST stock price today per share is 0.23 SEK.

How to purchase Bio Vitos Pharma AB (publ) stock?

You can buy HEMC.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Bio Vitos Pharma AB (publ)?

The stock symbol or ticker of Bio Vitos Pharma AB (publ) is HEMC.ST.

Which industry does the Bio Vitos Pharma AB (publ) company belong to?

The Bio Vitos Pharma AB (publ) industry is Medical Devices.

How many shares does Bio Vitos Pharma AB (publ) have in circulation?

The max supply of Bio Vitos Pharma AB (publ) shares is 38.02M.

What is Bio Vitos Pharma AB (publ) Price to Earnings Ratio (PE Ratio)?

Bio Vitos Pharma AB (publ) PE Ratio is 0.00000000 now.

What was Bio Vitos Pharma AB (publ) earnings per share over the trailing 12 months (TTM)?

Bio Vitos Pharma AB (publ) EPS is 0 SEK over the trailing 12 months.

Which sector does the Bio Vitos Pharma AB (publ) company belong to?

The Bio Vitos Pharma AB (publ) sector is Healthcare.

Bio Vitos Pharma AB (publ) HEMC.ST included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
First North Sweden SEK GI FNSESEKGI 1956.89 SEK 191.02 USD
-0.28
First North Sweden EUR GI FNSEEURGI 1570.14 EUR 1716.38 USD
-0.77
First North Health Care GI FN20GI 917.04 EUR 1002.44 USD
-1.17
First North All-Share EUR FIRSTNORTHEUR 97.9 EUR 107.01 USD
-0.64
First North Sweden SEK PI FNSESEKPI 1843.91 SEK 179.99 USD
-0.28
First North Sweden EUR PI FNSEEURPI 1479.5 EUR 1617.29 USD
-0.77
First North Health Care PI FN20PI 912.9 EUR 997.92 USD
-1.17
First North All-Share SEK FIRSTNORTHSEK 123.34 SEK 12.04 USD
-0.14
First North All-Share DKK FIRSTNORTHDKK 97.96 DKK 14.36 USD
-0.62